Sensus Healthcare Inc. (NASDAQ:SRTS) marked $6.40 per share on Wednesday, down from a previous closing price of $6.53. While Sensus Healthcare Inc. has underperformed by -1.99%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, SRTS rose by 8.66%, with highs and lows ranging from $15.25 to $5.56, whereas the simple moving average fell by -37.65% in the last 200 days.
Do You Own These 7 Inflation-Survival Stocks?
Inflation is still near 40-year highs and rising prices are putting a big dent in our wallets. Unless you find out how to protect your portfolio and outpace inflation, you'll keep being at the mercy of economic factors out of your control. Especially since the price of electricity, food, and shelter are creeping up higher than ever. In this special report, I detail 7 stocks to help you survive and thrive in today's market. They're backed by solid companies, positioned to profit during tough economic times, and offer out-sized dividends to help you outpace inflation.
Click here to get your free copy of the report
On February 26, 2021, Northland Capital Upgraded Sensus Healthcare Inc. (NASDAQ: SRTS) to Outperform. A report published by Northland Capital on December 16, 2020, Downgraded its rating to ‘Market Perform’ for SRTS. Alliance Global Partners also Upgraded SRTS shares as ‘Buy’, setting a target price of $4.25 on the company’s shares in a report dated August 10, 2020. B. Riley FBR November 07, 2019d its ‘Buy’ rating to ‘Neutral’ for SRTS, as published in its report on November 07, 2019. B. Riley FBR also rated the stock as ‘Buy’.
Analysis of Sensus Healthcare Inc. (SRTS)
Further, the quarter-over-quarter increase in sales is 63.60%, showing a positive trend in the upcoming months.
In order to gain a clear picture of Sensus Healthcare Inc.’s future performance, a variety of well-rounded analysis and research techniques can be applied, with equity being the most critical. The goal here is to ensure that your current return on equity of 66.60% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 7.50, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
An average volume of 435.02K can be a very valuable indicator of volatility for SRTS stock. On a monthly basis, the volatility of the stock is set at 9.48%, whereas on a weekly basis, it is put at 7.68%, with a loss of -11.97% over the past seven days. Furthermore, long-term investors anticipate a median target price of $15.30, showing growth from the present price of $6.40, which can serve as yet another indication of whether SRTS is worth investing in or should be passed over.
How Do You Analyze Sensus Healthcare Inc. Shares?
The USA based company Sensus Healthcare Inc. (SRTS) is one of the biggest names in Medical Devices. When comparing Sensus Healthcare Inc. shares with other companies under Healthcare, the P/E value is an influential factor to note. This is because it represents an indication of the future growth of the company in terms of investors’ expectations. Ultimately, the value of the latter should demonstrate steady, rapid growth, which is an accurate measure of the company’s progress. In addition to the value of 3.98, there is a growth in quarterly earnings of 832.40%.
In addition to the fundamentals, you should also consider how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 8.10%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 36.60% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
Are institutional investors increasing their holdings in SRTS shares?
The recent increase in stakes in SRTS appears to be a result of several institutional investors and hedge funds increasing their positions. Acadian Asset Management LLC’s position in SRTS has increased by 2.27% in the first quarter. The company now owns 595,619 shares of the stock, with a value of $8.38 million, following the purchase of 13,234 additional shares during the last quarter. During the last quarter, the company dropped down 0 additional shares for a total stake of worth $8.29 million, bringing number of shares owned by the company to 588,910.
At the end of the first quarter, EAM Investors LLC decreased its SRTS holdings by -0.52% and now holds 0.33 million SRTS shares valued at $4.6 million with the lessened 1719.0 shares during the period. SRTS shares are owned by institutional investors to the tune of 36.60% at present.